CGMs: GLP-1 Weight Loss At A Fraction Of The Cost | with Colin Rogers

“We show…very similar weight loss outcomes to GLP1 in a similar timeframe at a fraction of the cost, but sustainable through behavior change." - Colin Rogers

Colin Rogers, VP at Signos, joined me for episode 200! On this special episode, we talked about something I’m very passionate and vocal about: weight loss for everybody. 

Signos combines continuous glucose monitors (CGMs), our phones, and AI to track longitudinal data and help educate and prompt members to make better health decisions. If you’re into personalized population health, then this is the episode for you!

On one of our earliest episodes, a guest shared that the best way to solve the problem of healthcare is to produce less disease. GLP-1s definitely appear to have a role to play in that, but as Colin shares on this episode, the more we can achieve GLP-1 results in a way that’s sustainable, the better, for employers and for America.

Chapters:

(00:00:00) GLP-1 Weight Loss At A Fraction Of The Cost | with Colin Rogers
(00:11:29) Real-world CGM Data Impact
(00:15:26) Health Programs for Metabolism Control
(00:21:37) Real-time Glucose Monitoring Devices Empower Employees
(00:36:03) How CGMs Can Optimize A Health Plan
(00:42:05) Why This Data Is So Powerful

Key Links for Social:

@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFunded

Listen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02

Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286

Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/

Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/